Interactions of sulindac and its metabolites with phospholipid membranes: An explanation for the peroxidation protective effect of the bioactive metabolite
暂无分享,去创建一个
M. Lúcio | S. Reis | J. Lima | Diana Gaspar | H. Ferreira | F. Santos | L. Teixeira
[1] E. Fernandes,et al. Hydrogen peroxide scavenging activity by non-steroidal anti-inflammatory drugs. , 2005, Life sciences.
[2] Ilpo Vattulainen,et al. Distribution, Orientation, and Dynamics of DPH Probes in DPPC Bilayer , 2004 .
[3] S. Reis,et al. Influence of some anti-inflammatory drugs in membrane fluidity studied by fluorescence anisotropy measurementsPresented at the 17th Conference of the European Colloid & Interface Science Society, Firenze, Italy, September 21?26, 2003 , 2004 .
[4] S. Reis,et al. Zeta-potential measurements as a tool to quantify the effect of charged drugs on the surface potential of egg phosphatidylcholine liposomes. , 2004, Langmuir : the ACS journal of surfaces and colloids.
[5] M. Mora,et al. Interaction of tocopherols and phenolic compounds with membrane lipid components: evaluation of their antioxidant activity in a liposomal model system. , 2003, Life sciences.
[6] D. Latowski,et al. Thermotropic phase behaviour of alpha-dipalmitoylphosphatidylcholine multibilayers is influenced to various extents by carotenoids containing different structural features--evidence from differential scanning calorimetry. , 2003, Biochimica et biophysica acta.
[7] Dejian Huang,et al. High-throughput assay of oxygen radical absorbance capacity (ORAC) using a multichannel liquid handling system coupled with a microplate fluorescence reader in 96-well format. , 2002, Journal of agricultural and food chemistry.
[8] D. Praticò. Alzheimer's disease and oxygen radicals: new insights. , 2002, Biochemical pharmacology.
[9] A. Bennett,et al. COX-2 inhibitors compared and contrasted , 2001, Expert opinion on pharmacotherapy.
[10] R. Prior,et al. Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe. , 2001, Journal of agricultural and food chemistry.
[11] A. Wierzbicki,et al. Molecular modeling study of COX-2 inhibition by diarylheterocycles and sulindac sulfide , 2001 .
[12] D. Trombetta,et al. In vitro evaluation of the antioxidant activity and biomembrane interaction of the lazaroid U-74389G. , 2001, Life sciences.
[13] D. Ahnen,et al. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites. , 2001, Cancer research.
[14] A. Bennett,et al. Anti-inflammatory drugs, cyclooxygenases and other factors , 2001, Expert opinion on pharmacotherapy.
[15] J. McCord,et al. The evolution of free radicals and oxidative stress. , 2000, The American journal of medicine.
[16] R. Floyd. Antioxidants, oxidative stress, and degenerative neurological disorders. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[17] M. Prieto,et al. Interaction of the major epitope region of HIV protein gp41 with membrane model systems. A fluorescence spectroscopy study. , 1998, Biochemistry.
[18] London,et al. Location of diphenylhexatriene (DPH) and its derivatives within membranes: comparison of different fluorescence quenching analyses of membrane depth , 1998, Biochemistry.
[19] D. C. Mitchell,et al. Molecular order and dynamics in bilayers consisting of highly polyunsaturated phospholipids. , 1998, Biophysical journal.
[20] G. Strasburg,et al. Development and validation of fluorescence spectroscopic assays to evaluate antioxidant efficacy. Application to metal chelators , 1997 .
[21] Patrick L. McGeer,et al. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease , 1996, Neurology.
[22] A. Saija,et al. Flavonoids as antioxidant agents: importance of their interaction with biomembranes. , 1995, Free radical biology & medicine.
[23] D. Trombetta,et al. Flavonoid-biomembrane interactions: A calorimetric study on dipalmitoylphosphatidylcholine vesicles , 1995 .
[24] L. Barclay,et al. Membrane peroxidation: inhibiting effects of water-soluble antioxidants on phospholipids of different charge types. , 1994, Free radical biology & medicine.
[25] H. Garda,et al. Lipid chain order and dynamics at different bilayer depths in liposomes of several phosphatidylcholines studied by differential polarized phase fluorescence. , 1994, Chemistry and physics of lipids.
[26] B. Lentz,et al. Use of fluorescent probes to monitor molecular order and motions within liposome bilayers. , 1993, Chemistry and physics of lipids.
[27] D. Lasič,et al. Liposomes: From Physics to Applications , 1993 .
[28] A. Kaszniak,et al. Clinical trial of indomethacin in Alzheimer's disease , 1993, Neurology.
[29] D. Stolz,et al. The impenetrability of 5-(N-hexadecanoyl)aminofluoroscein through endothelial cell monolayers is dependent upon its solution properties, not the presence of tight junctions. , 1992, Biochemical and biophysical research communications.
[30] M. Prieto,et al. Location and interaction of N-(9-anthroyloxy)-stearic acid probes incorporated in phosphatidylcholine vesicles , 1991 .
[31] E Gratton,et al. Orientational distribution of 1,6-diphenyl-1,3,5-hexatriene in phospholipid vesicles as determined by global analysis of frequency domain fluorimetry data. , 1991, Biochemistry.
[32] E. Gratton,et al. A photophysical model for diphenylhexatriene fluorescence decay in solvents and in phospholipid vesicles. , 1991, Biophysical journal.
[33] B. Lentz,et al. Membrane “fluidity” as detected by diphenylhexatriene probes , 1989 .
[34] M. Masserini,et al. Studies on peroxidation of arachidonic acid in different liposomes below and above phase transition temperature. , 1988, Chemistry and physics of lipids.
[35] B. Halliwell,et al. Oxidants, inflammation, and anti‐inflammatory drugs , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] E. Oldfield,et al. Deuterium nuclear magnetic resonance spectroscopic study of the fluorescent probe diphenylhexatriene in model membrane systems. , 1986, Biochemistry.
[37] Y. K. Levine,et al. The static and dynamic behaviour of fluorescent probe molecules in lipid bilayers , 1986 .
[38] R. Dale,et al. Transverse location of the fluorescent probe 1,6-diphenyl-1,3,5-hexatriene in model lipid bilayer membrane systems by resonance excitation energy transfer. , 1985, Biochemistry.
[39] S. Fan,et al. Membrane effects of antiinflammatory agents. 1. Interaction of sulindac and its metabolites with phospholipid membrane, a magnetic resonance study. , 1981, Journal of medicinal chemistry.
[40] S. Hwang,et al. Membrane effects of antiinflammatory agents. 2. Interaction of nonsteroidal antiinflammatory drugs with liposome and purple membranes. , 1981, Journal of medicinal chemistry.
[41] Y. Barenholz,et al. Fluidity parameters of lipid regions determined by fluorescence polarization. , 1978, Biochimica et biophysica acta.
[42] A. Visser,et al. Fluorescence dynamics of diphenyl-1,3,5-hexatriene-labeled phospholipids in bilayer membranes. , 1994, Biophysical chemistry.
[43] B. Halliwell,et al. Role of free radicals and catalytic metal ions in human disease: an overview. , 1990, Methods in enzymology.
[44] R. New,et al. Liposomes : a practical approach , 1990 .
[45] J. Lakowicz. Principles of fluorescence spectroscopy , 1983 .